Matthew J. "Matt" Goggin

Matthew J. "Matt" Goggin


Carlson Caspers

Recognized since 2020

Minneapolis, Minnesota

Practice Areas

Litigation - Intellectual Property

Litigation - Patent

Spinning circle Big letter B

Matthew J. Goggin has successfully represented clients for over 25 years in patent litigation involving a broad spectrum of technologies spanning the commercial world – everything from flytraps and pitchforks to polymer gels, acoustical insulation, respirator masks, cardiovascular stents, prescription drugs, and patented features used in smartphones.

Location

  • Capella Tower, Suite 4200
    225 South Sixth Street
    Minneapolis, MN 55402

Bar Admissions

  • Minnesota, Minnesota Supreme Court
  • Minnesota, U.S. District Court for the District of Minnesota
  • Minnesota, U.S. Court of Appeals for the Federal Circuit

Court Admissions

  • U.S. Patent and Trademark Office

Recognized in The Best Lawyers in America® 2023 for work in:

  • Litigation - Intellectual Property
  • Litigation - Patent

3M Company v. Moldex

Using a limited but effective discovery plan, Carlson Caspers won a very favorable Markman ruling in this dispute related to several 3M patents covering disposable respirators with exhalation valves. 552 F. Supp. 2d 921 (D. Minn. 2008). Carlson Caspers also won summary judgment in 3M’s favor on the defendant’s counterclaim of patent unenforceability. 2008 US Dist LEXIS 60842 (D. Minn. Aug. 8, 2008). The case settled favorably to 3M soon thereafter.

In RE Gel-Filled Wrist Rests (on behalf of 3M Company)

Alan Carlson and Matthew Goggin successfully represented 3M in an ITC investigation and trial involving the importation of gel-filled computer wrist rests that infringed a 3M patent. After the investigation, the ITC found 3M’s patent was valid and infringed. These rulings were instrumental in securing the quick and successful settlement of litigation in district court against the three main infringers. ITC (2001).

Kemin Foods v. OmniActive Health Technologies

Carlson Caspers represented OmniActive, a world leader in the nutraceutical market, in a lawsuit brought by Kemin Foods in Florida for alleged infringement of a patent covering a purified form of the carotenoid lutein. Following full discovery, the case was settled without trial on favorable terms. Middle District of Florida (2009).

Spectralytics, Inc. v. Cordis Corporation and Norman Noble, Inc.

Carlson Caspers represented Spectralytics, Inc. against Cordis Corporation and its supplier Norman Noble in a three-week infringement trial involving a Spectralytics patent on a method of making cardiovascular stents with a laser. In this real life David and Goliath battle, Spectralytics, a small laser shop in Dassel, Minnesota, defeated industry colossus Cordis Corporation and won a jury verdict of $22.35 million in damages for patent infringement. District of Minnesota (2009).

Takeda Pharmaceutical Company et al. v. Watson Pharmaceuticals, Inc., et al. (ramelteon)

Carlson Caspers represented Watson in a patent infringement lawsuit by Takeda in an effort to defeat Watson’s FDA application to sell a generic version of Takeda’s Rozerem® sleep-aid. The case was settled without trial on favorable terms. District of Delaware (2011).

Takeda v. Watson (colchicine)

We represented Watson in this Hatch-Waxman patent litigation involving Watson’s ANDA for a generic version of Takeda’s Colcrys® colchicine tablets. Takeda asserted 17 patents covering several uses of colchicine.

Your browser is not fully compatible with our automatic printer friendly formatting.

Please use the print button to print this profile page.

Spinning circle Big letter B